Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.


The study of viruses and viral diseases.

vi′ro·log′i·cal (vī′rə-lŏj′ĭ-kəl), vi′ro·log′ic (-ĭk) adj.
vi·rol′o·gist n.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.


(Medicine) another word (esp US) for virological
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014

virologic, virological

adj virológico
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
Mentioned in ?
References in periodicals archive ?
Risk for death was reduced in patients with a sustained virologic response to DAA therapy (HR, 0.29; 95 percent CI, 0.18 to 0.47), but not in patients without a sustained virologic response (HR, 1.13; 95 percent CI, 0.55 to 2.33).
In the randomised cohort, rates of virologic suppression and immunologic response increased from Week 48 to Week 96 in this difficult-to-treat population with multidrug resistant HIV-1.
The primary endpoint for this study conducted exclusively in women, was previously presented, and demonstrated noninferior maintained virologic suppression, with a low frequency of serious adverse events and no emergent resistance at Week 48.
The 2013 UNAIDS 90:90:90 ambition highlights the importance of effective ART in the global response to HIV, advocating that the HIV epidemic can be curtailed if 90% of people living with HIV know their status, 90% of those diagnosed receive ART, and 90% of those on treatment achieve virologic suppression.
Diagnosis of pediatric HIV infection includes viral antibodies and virologic nucleic acid amplification tests.
The product, in combination with optimised background treatment, maintained virologic suppression from Week 24 to Week 48 in this difficult-to-treat population.
During the follow-up period after the cessation of NA therapy, clinical and virologic relapse was observed in 419 (60.6%) and 547 (79.2%) patients, respectively.
Recently, a randomized control trial comparing TDF monotherapy and ETV-TDF combination therapy in patients with LAM-resistant, ETV-resistant, and ADV-refractory CHB revealed no significant differences in HBV DNA <15 IU/mL and virologic breakthroughs between the two treatment groups [10, 14, 15].
Although physicians follow these suggestions, recent studies still indicate high virologic relapse rates ranging from 40% to 95% in the first year after NA cessation [9-12].
M2 PHARMA-October 23, 2017-Zepatier (Elbasvir and Grazoprevir) Achieves over 95% Sustained Virologic Response in US Veterans with Chronic HCV and CKD
(10) Increased use of single-tablet regimens (from 7% in 2006 to 27% in 2013) accounted for much of the improved adherence (adjusted risk ratio [aRR] 1.05, 95% CI 1.03 to 1.08), and single-tablet therapy raised chances of virologic suppression (aRR 1.06, 95% CI 1.01 to 1.11).